Have a feature idea you'd love to see implemented?
Let us know!
BJDX Bluejay Diagnostics Inc
Price (delayed)
$0.0995
Market cap
$622,093
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$43.92
Enterprise value
-$7.01M
Highlights
BJDX's equity has surged by 157% since the previous quarter and by 36% year-on-year
BJDX's quick ratio has soared by 125% from the previous quarter and by 41% YoY
Bluejay Diagnostics's debt has increased by 35% from the previous quarter
Key stats
What are the main financial stats of BJDX
Market
Valuations
Earnings
Shares outstanding
6.25M
Market cap
$622,093
Enterprise value
-$7.01M
Price to earnings (P/E)
N/A
Price to book (P/B)
0
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$8.78M
EBITDA
-$8.34M
Free cash flow
-$8.52M
Per share
Balance sheet
Liquidity
EPS
-$43.92
Free cash flow per share
-$17.63
Book value per share
$23.8
Revenue per share
$0
TBVPS
$22.48
Total assets
$10.86M
Total liabilities
$2.22M
Debt
$426,850
Equity
$8.64M
Working capital
$6.96M
Debt to equity
0.05
Current ratio
4.38
Quick ratio
3.92
Net debt/EBITDA
0.91
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-129.5%
Return on equity
-187%
Return on invested capital
-802.5%
Return on capital employed
-99.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BJDX stock price
How has the Bluejay Diagnostics stock price performed over time
Intraday
-11%
1 week
0.51%
1 month
-31.24%
1 year
-99.72%
YTD
-98.98%
QTD
-21.65%
Financial performance
How have Bluejay Diagnostics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$9.05M
Net income
-$9.4M
Gross margin
N/A
Net margin
N/A
BJDX's operating income is up by 17% year-on-year and by 10% since the previous quarter
BJDX's net income is up by 12% year-on-year and by 3.5% since the previous quarter
Growth
What is Bluejay Diagnostics's growth rate over time
Valuation
What is Bluejay Diagnostics stock price valuation
P/E
N/A
P/B
0
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
BJDX's EPS is up by 48% YoY and by 28% QoQ
BJDX's equity has surged by 157% since the previous quarter and by 36% year-on-year
BJDX's P/B is 100% below its last 4 quarters average of 0.5
Efficiency
How efficient is Bluejay Diagnostics business performance
Bluejay Diagnostics's return on equity has shrunk by 79% YoY but it has increased by 14% QoQ
Bluejay Diagnostics's return on invested capital has shrunk by 62% YoY and by 7% QoQ
The ROA has contracted by 47% YoY but it has grown by 11% from the previous quarter
Dividends
What is BJDX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BJDX.
Financial health
How did Bluejay Diagnostics financials performed over time
BJDX's quick ratio has soared by 125% from the previous quarter and by 41% YoY
The total assets has soared by 114% QoQ and by 28% YoY
Bluejay Diagnostics's debt is 95% less than its equity
BJDX's equity has surged by 157% since the previous quarter and by 36% year-on-year
The company's debt to equity fell by 44% QoQ and by 29% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.